Literature DB >> 9513857

Central nervous system complications after lung transplantation.

L S Goldstein1, M T Haug, J Perl, M K Perl, J R Maurer, A C Arroliga, A C Mehta, T Kirby, B Higgins, P C Stillwell.   

Abstract

PURPOSE: This study describes the central nervous system (CNS) events after lung transplantation.
METHODS: A chart review of all lung transplant recipients (LTR) to collect the clinical and neuroimaging data for CNS events defined as seizures, severe headaches, confusion, or stroke.
RESULTS: Twenty-six patients of 100 LTRs from 1990 through 1995 had a CNS event; more than one event occurred in 5 patients for a total of 32 events. Severe headache was most common, occurring in 14 patients, followed by seizures in 10, stroke in 5, and confusion in 3. The CNS event was related to infection in three of the 26 patients. Of all evaluations performed, magnetic resonance imaging (MRI) identified the most abnormalities, the most common being white matter changes consistent with cyclosporine toxicity. Cyclosporine levels were elevated in slightly more than half of the patients. Hypomagnesemia was present in three of 10 patients with seizures. Prognosis for recovery from these complications was good, with only five patients having ongoing problems with headaches, one requiring long term anticonvulsant therapy, three having minor or no limitations from stroke and no long-term problems with confusion. One patient with seizures resulting from an aspergilloma died.
CONCLUSION: CNS events occur commonly in LTRs, mostly related to cyclosporine toxicity or infection. MRI identifies more abnormalities than computed tomography. These events were not consistently associated with documented high cyclosporine levels and hypomagnesemia. In spite of significantly abnormal MRIs, the functional outcome is favorable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513857

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Headache in kidney transplantation.

Authors:  Ferdinando Maggioni; Maria Cristina Mantovan; Paolo Rigotti; Roberto Cadrobbi; Federico Mainardi; Edoardo Mampreso; Mario Ermani; Silvia Cortelazzo; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2009-08-27       Impact factor: 7.277

3.  The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.

Authors:  N Serkova; L Litt; D Leibfritz; B Hausen; R E Morris; T L James; L Z Benet; U Christians
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.

Authors:  Sophie Taque; Sylviane Peudenier; Sophie Gie; Marc Rambeau; Virginie Gandemer; Laure Bridoux; Pierre Bétrémieux; Loic De Parscau; Edouard Le Gall
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

5.  Influence of early neurological complications on clinical outcome following lung transplant.

Authors:  Josep Gamez; Maria Salvado; Alejandro Martinez-de La Ossa; Maria Deu; Laura Romero; Antonio Roman; Judith Sacanell; Cesar Laborda; Isabel Rochera; Miriam Nadal; Francesc Carmona; Estevo Santamarina; Nuria Raguer; Merce Canela; Joan Solé
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

6.  Imaging findings of neurologic complications in lung transplantation: Review of a 9-year cohort.

Authors:  Elena Marín-Díez; Marta Drake-Pérez; Natalia Valle-San Román; Víctor Manuel Mora Cuesta; Miguel Ángel Hernández-Hernández; Enrique Marco de Lucas
Journal:  Acta Radiol Open       Date:  2021-10-03

7.  Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study.

Authors:  Vasileios Andrianopoulos; Rainer Gloeckl; Martina Boensch; Katharina Hoster; Tessa Schneeberger; Inga Jarosch; Rembert A Koczulla; Klaus Kenn
Journal:  ERJ Open Res       Date:  2019-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.